Last updated: November 21, 2026
The top pharma companies in Hyderabad for 2027 are Dr. Reddy’s Laboratories, Aurobindo Pharma, Divi’s Laboratories, Hetero and Laurus Labs, followed by MSN Laboratories, Gland Pharma, Natco Pharma, Granules India and Neuland Laboratories. All ten are headquartered in Hyderabad, and together they make the city one of the world’s most important centres for generic medicines and active pharmaceutical ingredients.
Hyderabad is often called the bulk drug capital of India, because a large share of the country’s active pharmaceutical ingredient production happens in and around the city. The industry grew from the 1960s, when the public sector Indian Drugs and Pharmaceuticals Limited set up a plant here and trained a generation of chemists who went on to found many of today’s companies.
This list covers pharmaceutical companies headquartered in Hyderabad, ranked on scale, global reach, scientific capability and influence on the local industry. It does not include vaccine and biotech companies, which are covered in our list of biotech and life sciences companies in Hyderabad. Rankings are editorial and no company paid to appear.
| Company | Founded | Known For | Core Strength |
|---|---|---|---|
| Dr. Reddy’s Laboratories | 1984 | Generics, APIs and biosimilars worldwide | Hyderabad’s best-known global pharma company |
| Aurobindo Pharma | 1986 | US generics and injectables | One of the largest generic filers in the US |
| Divi’s Laboratories | 1990 | APIs and custom synthesis for global pharma | World-class API and custom synthesis |
| Hetero | 1993 | Generics, HIV medicines and biosimilars | Leader in affordable HIV medicines |
| Laurus Labs | 2005 | APIs, generics and CDMO services | Fast-growing API and CDMO company |
| MSN Laboratories | 2003 | APIs and finished formulations | Fast-growing API and formulations maker |
| Gland Pharma | 1978 | Injectables and CDMO | Injectables specialist |
| Natco Pharma | 1981 | Oncology and specialty generics | First-to-file specialty generics |
| Granules India | Long-established | High-volume APIs and formulations | Scale in widely used medicines |
| Neuland Laboratories | 1984 | APIs and custom manufacturing | Complex API and peptide specialist |
Dr. Reddy’s Laboratories was founded in Hyderabad in 1984 by Dr. K. Anji Reddy and has grown into one of India’s largest and most international pharmaceutical companies. It sells generic medicines, active pharmaceutical ingredients and biosimilars in markets including the United States, Europe, Russia and India.
The company is listed in India and on the New York Stock Exchange, and invests heavily in research and development, including complex generics and biologics. Its subsidiary Aurigene works in drug discovery and contract research.
Dr. Reddy’s has been central to Hyderabad’s rise as a pharma hub, training thousands of scientists and managers who now work across the industry.
For job seekers and partners, it offers global scale, a strong research culture and a long track record of regulatory approvals.
The company has also invested in sustainability, digital manufacturing and new therapy areas, and it runs a foundation focused on education and livelihoods. Its campus and research centres in Hyderabad remain among the most important life sciences workplaces in the city.
Aurobindo Pharma was founded in 1986 and is headquartered in Hyderabad. It is one of India’s largest pharmaceutical companies and among the biggest suppliers of generic medicines to the United States by volume.
Aurobindo has built broad capabilities across oral solids, injectables, specialty products and biosimilars, with manufacturing facilities in India and abroad.
Its vertical integration, from APIs to finished medicines, gives it cost advantages and supply security.
Aurobindo is a major employer in Telangana and Andhra Pradesh.
In recent years Aurobindo has expanded into biosimilars and vaccines through dedicated subsidiaries, and invested in specialty and complex injectables. These moves aim to reduce dependence on highly competitive oral generics.
Divi’s Laboratories was founded in 1990 by Dr. Murali Divi and is headquartered in Hyderabad. It is one of the world’s leading manufacturers of active pharmaceutical ingredients and a major custom synthesis partner for global pharmaceutical companies.
Divi’s is known for manufacturing efficiency, process chemistry expertise and consistently strong quality, which has made it a trusted partner for innovator companies.
It also produces nutraceutical ingredients such as carotenoids.
Its focus and execution have made it one of the most valuable pharma companies in India.
Many of the world’s best-known medicines rely on ingredients produced by companies like Divi’s, even though patients never see the supplier’s name. Long-term contracts with innovator companies give it unusually stable demand compared with typical generics makers.
Hetero was founded in 1993 and is headquartered in Hyderabad. It is one of the world’s largest producers of antiretroviral medicines for HIV and has played a major role in making these medicines affordable in developing countries.
Hetero also produces a wide range of generic medicines, APIs and biosimilars, and was involved in producing COVID-19 treatments in India.
The privately held group has manufacturing facilities in India and several other countries.
Its impact on global health access makes it one of Hyderabad’s most significant pharma companies.
Laurus Labs was founded in 2005 and is headquartered in Hyderabad. It began as a leading producer of APIs for antiretroviral and oncology medicines and has expanded into finished generics, contract development and manufacturing, and biotechnology through Laurus Bio.
Its contract research and manufacturing business, Laurus Synthesis, serves global innovator companies.
Laurus has invested in new capacity, including projects in Genome Valley.
Its rapid growth has made it one of the most closely watched pharma companies in India.
Laurus has been particularly active in building capacity for contract manufacturing as global pharma companies look to diversify supply chains beyond a single country, which could make it one of the main beneficiaries of that shift.
MSN Laboratories was founded in 2003 and is headquartered in Hyderabad. It has grown rapidly to become a significant producer of APIs and finished formulations for India and international markets.
MSN is known for being quick to launch new generics, including in oncology and other specialty areas.
The privately held company has multiple manufacturing sites in Telangana.
It is a major employer and a strong example of Hyderabad’s entrepreneurial pharma culture.
Gland Pharma was founded in Hyderabad in 1978 and specialises in injectable medicines, including vials, ampoules and pre-filled syringes, supplied mainly through partners to regulated markets.
Fosun Pharma of China is its majority shareholder, and the company is listed on Indian stock exchanges.
Injectables are complex to manufacture, so Gland’s expertise and regulatory approvals are valuable to partners.
It also offers contract development and manufacturing services.
Its customers include many of the world’s leading generics companies, which rely on Gland to manufacture injectables they then sell under their own names. That model gives Gland broad reach while keeping it largely out of public view.
Natco Pharma was founded in 1981 and is headquartered in Hyderabad. It is known for oncology and specialty generic medicines and for challenging patents to launch affordable versions of expensive drugs.
Natco often partners with international companies to launch complex generics in the United States.
It also has a crop health business.
Its focus on difficult products sets it apart from high-volume generics makers.
Natco’s strategy has made it a notable force in improving access to cancer treatment in India, where the cost of branded oncology drugs can be out of reach for many patients.
Granules India is headquartered in Hyderabad and is one of the world’s largest manufacturers of widely used medicines such as paracetamol, metformin and ibuprofen, across APIs, intermediates and finished doses.
Its focus on high-volume products requires efficient, large-scale manufacturing.
Granules has expanded into more complex generics and the US market.
Its scale makes it an important part of global supply chains for everyday medicines.
Neuland Laboratories was founded in 1984 and is headquartered in Hyderabad. It manufactures APIs and provides custom manufacturing for innovator companies, with growing work in complex chemistry and peptides.
Neuland serves customers in regulated markets and is known for quality and technical capability.
Its custom manufacturing business has grown as innovator companies diversify their supply chains.
It is a respected mid-sized player in Hyderabad’s API sector.
Distinguish between generics, APIs, contract manufacturing, injectables and specialty products. Each has different risks and opportunities.
Check US FDA inspection outcomes, warning letters and approvals, which strongly affect pharma businesses.
Look at research spending, complex product pipelines and patents.
Exposure to the US, Europe, India and emerging markets shapes growth and risk.
Companies that make their own APIs often have more control over cost and supply.
For job seekers, employee reviews and training programmes matter as much as size.
Biosimilars, peptides, injectables and CDMO services are key growth areas.
Environmental compliance and responsible manufacturing are increasingly important to partners and regulators.
Generic medicine prices tend to fall over time, especially in the United States. Companies with complex products, specialty medicines, contract manufacturing or biologics are usually better protected than those relying on high-volume commodity drugs.
We assessed each Hyderabad-headquartered company on scale, global reach, product focus, scientific capability, regulatory track record and influence on the local industry, using company reports, public filings and industry coverage. Rankings are editorial and no company paid for placement. Read more about how we research and rank.
Because several of these companies are privately held, we relied on official company information and reputable industry reporting rather than financial filings for some details, and avoided ranking purely by revenue.
Because a large share of India’s active pharmaceutical ingredient production happens in and around Hyderabad, supported by decades of industry growth.
Dr. Reddy’s Laboratories and Aurobindo Pharma are among the largest Hyderabad-headquartered pharma companies.
An active pharmaceutical ingredient is the substance in a medicine that produces its therapeutic effect.
A contract development and manufacturing organisation develops and makes medicines or ingredients for other pharmaceutical companies.
It is a planned pharmaceutical manufacturing cluster on the outskirts of Hyderabad, intended to bring production facilities into one regulated zone.
Yes, particularly for chemists, quality, regulatory, manufacturing and research roles.
Genome Valley is Hyderabad’s life sciences cluster, home to vaccine makers, biotech companies and research organisations.
Hetero, Aurobindo and Laurus Labs are major producers of antiretroviral medicines and ingredients.
Yes. Many earn most of their revenue from exports to the US, Europe and other markets.
Most companies have procurement and business development teams. Quality certifications and regulatory compliance are essential.
Hyderabad’s pharma industry combines global generics leaders such as Dr. Reddy’s, Aurobindo and Hetero with API and manufacturing specialists such as Divi’s, Laurus Labs, MSN, Granules and Neuland, and focused players such as Gland Pharma in injectables and Natco in oncology.
Together, they make Hyderabad essential to global medicine supply. For related companies, see our lists of biotech and life sciences companies and recruitment agencies in Hyderabad, and the Hyderabad hub.